$DX
DYNEX CAPITAL INC Stock $dx

$dx Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000082667521000033 Filed on May 03, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$13.90M	$39.80M
YoY Change	-65.08%	-0.5%
Cost Of Revenue	$1.600M	$22.10M
YoY Change	-92.76%	-15.97%
Gross Profit	$12.30M	$17.70M
YoY Change	-30.51%	29.2%
Gross Profit Margin	88.49%	44.47%
Selling, General & Admin	$5.500M	$4.600M
YoY Change	19.57%	15.0%
% of Gross Profit	44.72%	25.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$600.0K	$500.0K
YoY Change	20.0%	150.0%
% of Gross Profit	4.88%	2.82%
Operating Expenses	$5.900M	$5.000M
YoY Change	18.0%	19.05%
Operating Profit	$6.400M	$12.70M
YoY Change	-49.61%	33.68%
Interest Expense	$1.633M	$22.10M
YoY Change	-92.61%	-15.89%
% of Operating Profit	25.52%	174.02%
Other Income/Expense, Net
YoY Change
Pretax Income	$117.9M	-$98.50M
YoY Change	-219.7%	88.7%
Income Tax
% Of Pretax Income
Net Earnings	$117.9M	-$98.48M
YoY Change	-219.75%	88.61%
Net Earnings / Revenue	848.41%	-247.43%
Basic Earnings Per Share	$4.20
Diluted Earnings Per Share	$4.20	-$4.283M
COMMON SHARES
Basic Shares Outstanding	26.79M shares	22.95M shares
Diluted Shares Outstanding	26.79M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$328.9M	$51.40M
YoY Change	539.88%	-8.05%
Cash & Equivalents	$328.9M	$51.41M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$20.50M	$1.527B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$349.4M	$1.578B
YoY Change	-77.86%	1824.51%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.386B	$3.728B
YoY Change	-35.99%	-23.19%
Other Assets	$49.20M	$59.20M
YoY Change	-16.89%	-31.8%
Total Long-Term Assets	$2.552B	$3.796B
YoY Change	-32.78%	-23.36%
TOTAL ASSETS
Total Short-Term Assets	$349.4M	$1.578B
Total Long-Term Assets	$2.552B	$3.796B
Total Assets	$2.901B	$5.374B
YoY Change	-46.02%	6.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$400.0K	$9.600M
YoY Change	-95.83%	-25.58%
Deferred Revenue
YoY Change
Short-Term Debt	$2.032B	$4.408B
YoY Change	-53.9%	3.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.063B	$4.806B
YoY Change	-57.08%	8.63%
LONG-TERM LIABILITIES
Long-Term Debt	$83.80M	$2.200M
YoY Change	3709.09%	-31.25%
Other Long-Term Liabilities	$23.50M	$15.90M
YoY Change	47.8%	367.65%
Total Long-Term Liabilities	$107.3M	$18.10M
YoY Change	492.82%	174.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.063B	$4.806B
Total Long-Term Liabilities	$107.3M	$18.10M
Total Liabilities	$2.170B	$4.824B
YoY Change	-55.02%	8.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$389.3M	-$729.3M
YoY Change	-46.62%	56.29%
Common Stock	$997.3M	$858.2M
YoY Change	16.21%	-1.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$731.3M	$550.6M
YoY Change
Total Liabilities & Shareholders Equity	$2.901B	$5.374B
YoY Change	-46.02%	6.73%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$117.9M	-$98.48M
YoY Change	-219.75%	88.61%
Depreciation, Depletion And Amortization	$600.0K	$500.0K
YoY Change	20.0%	150.0%
Cash From Operating Activities	$30.19M	$43.98M
YoY Change	-31.36%	9.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$398.3M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$398.3M	$287.9M
YoY Change	38.37%	-128.58%
FINANCING ACTIVITIES
Cash Dividend Paid	$13.32M	$15.03M
YoY Change	-11.36%	-32.59%
Common Stock Issuance & Retirement, Net	-$128.2M	$206.0K
YoY Change	-62308.74%	-100.38%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$360.8M	-$352.3M
YoY Change	2.41%	-134.51%
NET CHANGE
Cash From Operating Activities	$30.19M	$43.98M
Cash From Investing Activities	$398.3M	$287.9M
Cash From Financing Activities	-$360.8M	-$352.3M
Net Change In Cash	$67.76M	-$20.43M
YoY Change	-431.65%	-137.86%
FREE CASH FLOW
Cash From Operating Activities	$30.19M	$43.98M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000826675
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	1-9819
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	DYNEX CAPITAL, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-1549373
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4991 Lake Brook Drive
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Glen Allen,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23060-9245
CY2021Q1	dei	City Area Code CityAreaCode	(804)
CY2021Q1	us-gaap	Financial Instruments Owned Other At Fair Value FinancialInstrumentsOwnedOtherAtFairValue	5749000	USD
CY2020Q4	us-gaap	Financial Instruments Owned Other At Fair Value FinancialInstrumentsOwnedOtherAtFairValue	6264000	USD
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	217-5800
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30879569	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328936000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295602000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	49180000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	14758000	USD
CY2021Q1	us-gaap	Pledged Financial Instruments Not Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedFinancialInstrumentsNotSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	2173333000	USD
CY2020Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedFinancialInstrumentsNotSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	2467859000	USD
CY2021Q1	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	2380373000	USD
CY2020Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	2596255000	USD
CY2021Q1	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	5067000	USD
CY2020Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	150432000	USD
CY2021Q1	us-gaap	Derivative Assets DerivativeAssets	109746000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	11342000	USD
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	15480000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	14388000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6577000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6394000	USD
CY2021Q1	us-gaap	Assets Assets	2901108000	USD
CY2020Q4	us-gaap	Assets Assets	3095435000	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2032089000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2437163000	USD
CY2021Q1	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	24455000	USD
CY2020Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	5000	USD
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	19866000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1634000	USD
CY2021Q1	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	83776000	USD
CY2020Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	7681000	USD
CY2021Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	418000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1410000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5639000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5814000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	3589000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	8275000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	2169832000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2461982000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4460000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4460000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7248330	shares
CY2020Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	174564000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7248330	shares
CY2021Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	111500000	USD
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	181208000	USD
CY2021Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	107843000	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30879569	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30879569	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23697970	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23697970	shares
CY2021Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	309000	USD
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	237000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	997326000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	869495000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15105000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	80261000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-389307000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-491104000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	731276000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	633453000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2901108000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3095435000	USD
CY2021Q1	us-gaap	Interest Income Operating InterestIncomeOperating	13892000	USD
CY2020Q1	us-gaap	Interest Income Operating InterestIncomeOperating	39822000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1633000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	22101000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12259000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17721000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	4697000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	84783000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-980000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-372000	USD
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	107801000	USD
CY2020Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-195567000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-380000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-423000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3096000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2163000	USD
CY2021Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2372000	USD
CY2020Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2458000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	117929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-98479000	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2559000	USD
CY2020Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3841000	USD
CY2021Q1	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	2987000	USD
CY2020Q1	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	3914000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	112383000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-106234000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-60459000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	157755000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	4697000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	84783000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-65156000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	72972000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	47227000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33262000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	4.20
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.63
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26788693	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22963084	shares
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	582988000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	107988000	USD
CY2020Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	100000000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	307000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	206000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	235000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	9000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-98479000	USD
CY2020Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	3841000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10330000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	72972000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	550607000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	633453000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	128150000	USD
CY2021Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	69708000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	451000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	428000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	270000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	117929000	USD
CY2021Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2559000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10586000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-65156000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	731276000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	117929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-98479000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	107801000	USD
CY2020Q1	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	-195567000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	4697000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	84783000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-980000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-372000	USD
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30161000	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	33118000	USD
CY2021Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	599000	USD
CY2020Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	499000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	452000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	307000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1092000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-3105000	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-992000	USD
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-5979000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5350000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-254000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30189000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	43981000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	68543000	USD
CY2020Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	155594000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	118022000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	140032000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	220194000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	487464000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	488000	USD
CY2020Q1	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	615000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-52079000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	187822000	USD
CY2021Q1	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	76095000	USD
CY2020Q1	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	3185000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	398335000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	287880000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4494067000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	16555552000	USD
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	4899141000	USD
CY2020Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	16899794000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-118000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-569000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	107988000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	128150000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	69708000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	100000000	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	270000	USD
CY2020Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	206000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	428000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	235000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	13320000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	15027000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-360768000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-352291000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	67756000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-20430000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310360000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136230000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	378116000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115800000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	2619000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	28074000	USD
CY2021Q1	us-gaap	Nature Of Operations NatureOfOperations	OrganizationDynex Capital, Inc. (“Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company is an internally managed mortgage real estate investment trust, or mortgage REIT, which primarily earns income from investing on a leveraged basis in debt securities, the majority of which are specified pools of Agency mortgage-backed securities (“MBS”) consisting of commercial MBS (“CMBS”), residential MBS (“RMBS”), and CMBS interest-only (“IO”) securities and non-Agency MBS, which consist mainly of CMBS IO. Agency MBS have a guaranty of principal payment by a U.S. government-sponsored entity (“GSE”) such as Fannie Mae and Freddie Mac, which are in conservatorship and are currently supported by a senior preferred stock purchase agreement from the U.S. Treasury. Non-Agency MBS are issued by non-governmental enterprises and do not have a guaranty of principal payment. The Company also invests in other types of mortgage-related securities, such as to-be-announced securities (“TBAs” or “TBA securities”).
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts and fair value measurements of its investments. These items are discussed further below within this note to the consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the estimates and assumptions underlying the consolidated financial statements included herein are reasonable and supportable based on the information available as of March 31, 2021; however, the uncertainty over the impact that the COVID-19 pandemic may continue to have on the global economy and on the Company’s business makes any estimates and assumptions inherently less certain than they would be absent the current and potential impacts of COVID-19. The COVID-19 pandemic and resulting emergency measures have led (and may continue to lead) to significant disruptions in the global capital markets and supply chains as well as the economy of the U.S. and other countries impacted by COVID-19. In particular, as part of the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act passed by the U.S. Congress, which includes assistance to homeowners and renters, both Fannie Mae and Freddie Mac have implemented mortgage forbearance policies that allow borrowers to delay their mortgage payments for up to 18 months and placed a moratorium on foreclosures on single-family homes until June 30, 2021. The impact of high levels of forbearance on the Company’s MBS could range from immaterial to significant depending upon not only actual losses incurred on underlying loans but also future public policy choices and actions by the GSEs, their regulator the Federal Housing Finance Agency (“FHFA”), the U.S. Federal Reserve (“Federal Reserve”), and federal and state governments. The nature and timing of any such future public policy choices and actions are unpredictable, including the potential impact on MBS prices and prepayment speeds. Though these supportive actions have helped cushion the economic damage from the disruption of the </span></div>pandemic to date, the Company can give no assurance as to how, in the long term, these and other actions by the U.S. government and GSEs will affect the efficiency, liquidity and stability of the financial and mortgage markets.
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain items on the Company’s consolidated balance sheet as of December 31, 2020 have been reclassified to conform to the current period’s presentation. In the Company’s 2020 Form 10-K, restricted cash on the consolidated balance sheet as of December 31, 2020 consisted of the cash collateral posted by the Company to its counterparties to cover initial and variation margin related to its financing and derivative instruments, net of any cash collateral received by the Company from its counterparties. Restricted cash has been renamed “cash collateral posted to counterparties” within total assets, and cash collateral of $7,681 posted by counterparties as of December 31, 2020 has been reclassified to “cash collateral posted by counterparties” within total liabilities.</span></div>
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	7681000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328936000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	49180000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	378116000	USD
CY2021Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	As previously disclosed in the 2020 Form 10-K, the receiver (the “Receiver”) for one of the plaintiffs awarded damages in a judgment (the "DCI Judgment") against Dynex Commercial, Inc. ("DCI"), a subsidiary of a former affiliate of the Company, filed a separate claim in May 2018 against the Company seeking payment of the damages awarded in connection with the DCI Judgment, alleging that the Company breached a litigation cost sharing agreement, as amended (the "Agreement"), that was initially entered into by the Company and DCI in December 2000. On November 21, 2019, the U.S. District Court, Northern District of Texas ("Northern District Court") granted in part and denied in part summary judgment on the Receiver’s claim and the Company’s claim for offset and recoupment. The Northern District Court found that the Company breached the Agreement and therefore must pay damages to the Receiver. The Northern District Court simultaneously granted the Company’s motion for summary judgment finding that DCI also breached the Agreement and that the Company can recover amounts due to it from DCI under the Agreement. The Receiver subsequently filed a claim for damages with the Northern District Court of approximately $12,600, while the Company filed claims for damages ranging from $13,300 to $30,600, including interest. The Receiver filed objections (the "Objections") with the Northern District Court to, among other things, the Company recovering amounts incurred prior to entry into the Agreement and amounts incurred under the Agreement after January 31, 2006, including interest, which is the date that DCI’s corporate existence ceased under Virginia law. The Company has disputed the Receiver’s Objections, arguing, among other things, that the Receiver's Objections are not supportable under Virginia law and has further refined its damages claim to range from $15,961 based on simple interest to $22,752 based on a combination of simple and compound interest, which the Company believes is supportable under Virginia law. There have been no material developments in this matter during the three months ended March 31, 2021. After consultation with litigation counsel, the Company believes, based upon information currently available and its evaluation of Virginia law, that the likelihood of loss is not probable, and given the range of potential claims for damages by the Company to offset the Receiver's claims, the amount of possible loss cannot be reasonably estimated, and therefore, no contingent liability has been recorded.
CY2021Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	12600000	USD
CY2021Q1	us-gaap	Loss Contingency Inestimable Loss LossContingencyInestimableLoss	After consultation with litigation counsel, the Company believes, based upon information currently available and its evaluation of Virginia law, that the likelihood of loss is not probable, and given the range of potential claims for damages by the Company to offset the Receiver's claims, the amount of possible loss cannot be reasonably estimated, and therefore, no contingent liability has been recorded.
CY2021Q1	dx	Parvalueofavailableforsaledebtsecurity Parvalueofavailableforsaledebtsecurity	1887309000	USD
CY2021Q1	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	410378000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2297687000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	40599000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25495000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2312791000	USD
CY2021Q1	dx	Par Value Of Debt Security Fair Value Option Elected ParValueOfDebtSecurityFairValueOptionElected	67692000	USD
CY2021Q1	us-gaap	Trading Securities Debt Amortized Cost TradingSecuritiesDebtAmortizedCost	68542000	USD
CY2021Q1	us-gaap	Debt Securities Trading Unrealized Gain DebtSecuritiesTradingUnrealizedGain	0	USD
CY2021Q1	us-gaap	Debt Securities Trading Unrealized Loss DebtSecuritiesTradingUnrealizedLoss	960000	USD
CY2021Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	67582000	USD
CY2021Q1	us-gaap	Debt Securities Trading And Available For Sale DebtSecuritiesTradingAndAvailableForSale	2380373000	USD
CY2020Q4	dx	Parvalueofavailableforsaledebtsecurity Parvalueofavailableforsaledebtsecurity	2076346000	USD
CY2020Q4	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	439649000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2515995000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	81293000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1033000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2596255000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2596255000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	74829000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	4697000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1991034000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	84783000	USD
CY2020Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	2
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2021Q1	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	2032089000	USD
CY2021Q1	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0026
CY2021Q1	us-gaap	Assets Sold Under Agreements To Repurchase Carrying Amounts AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts	2173333000	USD
CY2020Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	2437163000	USD
CY2020Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0034
CY2020Q4	us-gaap	Assets Sold Under Agreements To Repurchase Carrying Amounts AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts	2609075000	USD
CY2020Q4	dx	Amortized Cost Of Securities Sold But Unsettled AmortizedCostOfSecuritiesSoldButUnsettled	141215000	USD
CY2020Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	150432000	USD
CY2020Q4	dx	Repurchase Agreement Amount Outstanding For Which Securities Sold But Not Settled As Of The Reporting Date Are Pledged As Collateral RepurchaseAgreementAmountOutstandingForWhichSecuritiesSoldButNotSettledAsOfTheReportingDateArePledgedAsCollateral	140612000	USD
CY2021Q1	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	24455000	USD
CY2020Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	5000	USD
CY2021Q1	dx	Number Of Counterparties Borrowings Outstanding NumberOfCounterpartiesBorrowingsOutstanding	20	Agreements
CY2021Q1	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	2032089000	USD
CY2021Q1	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0026
CY2021Q1	dx	Originaltermtomaturity Originaltermtomaturity	30
CY2020Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	2437163000	USD
CY2020Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0034
CY2020Q4	dx	Originaltermtomaturity Originaltermtomaturity	44
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	250000000	USD
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	114251000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0097
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2032089000	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2032089000	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	2032089000	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	2437163000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2437163000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	2437163000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	107801000	USD
CY2020Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-195567000	USD
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	109746000	USD
CY2020Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	11342000	USD
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	19866000	USD
CY2020Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	1634000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	109746000	USD
CY2021Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2021Q1	us-gaap	Derivative Assets DerivativeAssets	109746000	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	54273000	USD
CY2021Q1	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	55473000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	11342000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	11342000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	107000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	7681000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	3554000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	19866000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	19866000	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	19866000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1634000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1634000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	107000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	1527000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	2987000	USD
CY2021Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2021-01-13
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.13
CY2021Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2021-02-11
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.13
CY2021Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2021-03-11
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.13
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2300000	shares
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	452000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	307000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D

Files In Submission

Name	View Source	Status
0000826675-21-000033-index-headers.html	Edgar Link	pending
0000826675-21-000033-index.html	Edgar Link	pending
0000826675-21-000033.txt	Edgar Link	pending
0000826675-21-000033-xbrl.zip	Edgar Link	pending
a1q21ex-311ceocertification.htm	Edgar Link	pending
a1q21ex-312cfocertification.htm	Edgar Link	pending
a1q21ex-321soxcertification.htm	Edgar Link	pending
dx-20210331.htm	Edgar Link	pending
dx-20210331.xsd	Edgar Link	pending
dx-20210331_cal.xml	Edgar Link	unprocessable
dx-20210331_def.xml	Edgar Link	unprocessable
dx-20210331_g1.jpg	Edgar Link	pending
dx-20210331_g2.jpg	Edgar Link	pending
dx-20210331_g3.jpg	Edgar Link	pending
dx-20210331_htm.xml	Edgar Link	completed
dx-20210331_lab.xml	Edgar Link	unprocessable
dx-20210331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DX
DYNEX CAPITAL INC Stock $dx

2021 Q1 Form 10-Q Financial Statement

#000082667521000033 Filed on May 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX DYNEX CAPITAL INC Stock $dx

2021 Q1 Form 10-Q Financial Statement

#000082667521000033 Filed on May 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX
DYNEX CAPITAL INC Stock $dx